Cargando…

Correlation of the combined symptom and medication score with quality of life, symptom severity and symptom control in allergic rhinoconjunctivitis

BACKGROUND: The European Academy of Allergy and Clinical Immunology recommended the Combined Symptom and Medication Score (CSMS) as primary endpoint in clinical trials on allergen‐specific immunotherapy (AIT) in allergic rhinoconjunctivitis. Here, the correlation between the CSMS and the validated s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palathumpattu, Binoy, Pieper‐Fürst, Ursula, Acikel, Cengizhan, Sahin, Hacer, Allekotte, Silke, Singh, Jaswinder, Hess, Mark, Sager, Angelika, Müller, Thomas, Mösges, Ralph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533220/ https://www.ncbi.nlm.nih.gov/pubmed/36225263 http://dx.doi.org/10.1002/clt2.12191

Ejemplares similares

Effectiveness of Ectoin lozenges on oropharyngeal allergic symptoms
por: Khachouk, Rawan, et al.
Publicado: (2022)

A meta‐analysis on allergen‐specific immunotherapy using MCT(®) (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis
por: Becker, Sven, et al.
Publicado: (2021)

Effects of ectoine containing nasal spray and eye drops on symptoms of seasonal allergic rhinoconjunctivitis
por: Salapatek, Anne M., et al.
Publicado: (2021)

Effectiveness and Tolerability of Ectoin(®) Mouth and Throat Spray Althaea Honey (ERS09) for Sore Throat due to Acute Pharyngitis and Dry Cough: A Multicentre, Actively Controlled, Open Label Study in Germany
por: Roventa, Don Lorenzo Constantin, et al.
Publicado: (2023)

Ultra‐short‐course booster is effective in recurrent grass pollen‐induced allergic rhinoconjunctivitis
por: Pfaar, O., et al.
Publicado: (2017)

Meta-Analysis of the Efficacy of Ectoine Nasal Spray in Patients with Allergic Rhinoconjunctivitis
por: Eichel, Andrea, et al.
Publicado: (2014)

Rhinosinusitis Treatment with Cineole: Patient-Reported Quality of Life Improvements from a Non-Interventional, Pharmacy-Based Survey
por: Werkhäuser, Nina, et al.
Publicado: (2023)

Allergic rhinoconjunctivitis
por: Miraglia del Giudice, Michele, et al.
Publicado: (2020)

Nonpharmacological Treatment of Rhinoconjunctivitis and Rhinosinusitis
por: Mösges, Ralph, et al.
Publicado: (2014)

Liposomes: a new non-pharmacological therapy concept for seasonal-allergic-rhinoconjunctivitis
por: Böhm, M., et al.
Publicado: (2011)

Subcutaneous immunotherapy with depigmented-polymerized allergen extracts: a systematic review and meta-analysis
por: Mösges, Ralph, et al.
Publicado: (2019)

PD14 - Non-interventional 2-year study of sublingual immunotherapy in children and adolescents with allergic rhinoconjunctivitis caused by grass pollen
por: Karagiannis, Efstrathios, et al.
Publicado: (2014)

7 Comparison of Efficacy and Safety of a Dipigmented Polymerized Allergen Extract of Grass and Birch with Placebo in Patients With Type-1 Allergic Rhinoconjunctivitis
por: Sager, Angelika, et al.
Publicado: (2012)

Allergic Rhinoconjunctivitis: the Role of Histamine
por: Andersson, M., et al.
Publicado: (1994)

Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022)

Iodixanol nasal solution reduces allergic rhinoconjunctivitis signs and symptoms in Allergen BioCube(®): a randomized clinical trial
por: Gomes, Paul J, et al.
Publicado: (2019)

Early nonreactivity in the conjunctival provocation test predicts beneficial outcome of sublingual immunotherapy
por: Köther, Janina, et al.
Publicado: (2018)

Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double‐blind, placebo‐controlled trial
por: Mösges, R., et al.
Publicado: (2018)

Allergic rhinitis, rhinoconjunctivitis and hayfever symptoms among children are associated with frequency of truck traffic near residences: a cross sectional study
por: Shirinde, Joyce, et al.
Publicado: (2015)

Can Twitter Be a Source of Information on Allergy? Correlation of Pollen Counts with Tweets Reporting Symptoms of Allergic Rhinoconjunctivitis and Names of Antihistamine Drugs
por: Gesualdo, Francesco, et al.
Publicado: (2015)

Relationship between allergic rhinitis and allergic conjunctivitis (allergic rhinoconjunctivitis) - review
por: Iordache, Andreea, et al.
Publicado: (2022)

Ivy leaves extract EA 575 in the treatment of cough during acute respiratory tract infections: meta-analysis of double-blind, randomized, placebo-controlled trials
por: Völp, Andreas, et al.
Publicado: (2022)

Effect of Montelukast on the Symptom Severity Score of Allergic Rhinitis
por: Rajput, Muhammad Shaheryar Ahmed, et al.
Publicado: (2020)

Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I
por: Strachan, David P., et al.
Publicado: (2021)

Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria
por: Sadaba, Belen, et al.
Publicado: (2013)

Allergic rhinoconjunctivitis: pathophysiological mechanism and new therapeutic approach
por: Ciprandi, Giorgio, et al.
Publicado: (2020)

Complementary treatment of allergic rhinoconjunctivitis: the role of the nutraceutical Lertal®
por: Marseglia, Gianluigi, et al.
Publicado: (2020)

Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis
por: Ferreli, Fabio, et al.
Publicado: (2020)

408 Prevalence and Risk Factors Associated to Symptoms of Rhinoconjunctivitis in Mexican School Children. A Multicenter Study
por: Livano Prez, Mayra Alondra, et al.
Publicado: (2012)

Hemorrhage rate after coblation tonsillectomy: a meta-analysis of published trials
por: Mösges, Ralph, et al.
Publicado: (2011)

Treatment of allergic rhinoconjunctivitis: a review of the role of topical levocabastine
por: Wijk, R. Gerth van
Publicado: (1995)

Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis
por: Aneeza, W. Hamizan, et al.
Publicado: (2013)

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2016)

Ragweed-induced allergic rhinoconjunctivitis: current and emerging treatment options
por: Ihler, Friedrich, et al.
Publicado: (2015)

Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis
por: Penagos, Martin, et al.
Publicado: (2018)

Naso-ocular neuropeptide interactions in allergic rhinoconjunctivitis, rhinitis, and conjunctivitis
por: Meng, Yifan, et al.
Publicado: (2021)

A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies
por: Hellings, Peter, et al.
Publicado: (2015)

233 The Evaluation of Allergen Sensitivity in Allergic Rhinoconjunctivitis and Allergic Asthma Patients in Antalya, Turkey
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Characterization of dysbiosis of the conjunctival microbiome and nasal microbiome associated with allergic rhinoconjunctivitis and allergic rhinitis
por: Wang, Yuan, et al.
Publicado: (2023)

Nasal-Ocular Reflexes and Their Role in the Management of Allergic Rhinoconjunctivitis With Intranasal Steroids
por: Baroody, Fuad M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gbh9218jn8459bf6v6qeetknrl